Patients with diabetes have a two-fold increase in the risk of heart failure (HF).

Diabetes and stroke, with an interlinking aetiology, contribute to a growing cardiovascular disease burden and mortality around the world…

Healthcare disparities and inequality are concepts that reflect aspects of differential healthcare access, disease and symptom management, and healthcare outcomes. Health inequalities can be defined as the “preventable, unfair and unjust differences in health status between groups, populations, or individuals that arise from the unequal distribution of social, environmental, and economic conditions within societies, which determine the risk of people getting ill, their ability to prevent sickness, or opportunities to take action and access treatment when ill health occurs.”1 Historically, disparities purely referred to a difference of some kind but, in recent years, the term has come to be synonymous with unfairness and inequality.

People with long-term conditions such as diabetes are at greater risk of comorbidity, and anecdotal evidence suggests that it can increase the burden of ongoing COVID-19 pandemic infection.1-3

Amivantamab has the potential to address the high unmet need in the treatment of people with EGFR exon 20 insertion mutations in non-small cell lung cancer

In this feature paper, the authors discuss the prevalence and pathophysiology of rheumatologic conditions, specifically ankylosing spondylitis and rheumatoid arthritis, in patients with hEDS.

Recent reports have also found dangerously high levels of toxic heavy metals, including cadmium, in several brands of baby food…

The research further suggests that the minimal allergic reactions could be avoided by manufacturers through the reformulation of vaccines…

While the potential of cell and gene therapies (CGTs) is huge, the high cost raises concerns from payers. We explore how the industry can drive the adoption of CGTs to ensure that they reach patients around the world, rather than just those in private markets